ArticleJournal of pharmaceutical policy and practice2025
Hypertension care: the knowledge and attitudes of the community pharmacists.
Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From transaction to transformation: a binational perspective on integrating community pharmacy into the digital health ecosystem of Southern European health systems.Journal of pharmaceutical policy and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension is a major global risk factor for cardiovascular disease and mortality. In Greece, prevalence is about 40%, with many cases undiagnosed or poorly managed. While doctors remain central to diagnosis and treatment, community pharmacists, as accessible healthcare professionals, can support early detection and ongoing management. This study assesses Greek community pharmacists' knowledge of hypertension detection and management, focusing on their ability to measure blood pressure accurately, categorise hypertension, and understand lifestyle factors. Methods: A cross-sectional survey was conducted with 92 community pharmacists in Greece, using a structured questionnaire to assess knowledge of blood pressure measurement, hypertension categorisation, and lifestyle influences. The instrument collected demographic data and responses on hypertension management practices. Data were gathered between December 2022 and April 2023 and analysed using SPSS v22. Results: The survey revealed moderate to good knowledge levels among pharmacists, particularly in blood pressure measurement (mean score: 71.74%, SD = 16.08) and hypertension categorisation (mean score: 76.9%, SD = 8.48). Knowledge about lifestyle impacts on blood pressure was lower (mean score: 53.57%, SD = 15.65). Younger pharmacists (26 36 years old) demonstrated significantly higher lifestyle impact knowledge (p = 0.013) and overall knowledge scores (p = 0.012) compared to the rest of the age groups, whereas pharmacists with postgraduate degrees had significantly higher scores in blood pressure measurement (p = 0.009) and overall knowledge scores (p = 0.002) compared to those with only a tertiary education. Conclusion: Findings underscore early undergraduate training and continuous professional development to strengthen pharmacists' hypertension-management role. Targeted programmes should deepen understanding of lifestyle determinants. Greek community pharmacists are well positioned for early detection within multidisciplinary care, yet more education is needed to optimise impact. The Panhellenic Pharmaceutical Association and Federation of Cooperative Pharmacists of Greece advocate recognising pharmacists' role in structured, advanced services, including hypertension management, to improve public health in Greece.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.